Clinical Trial Update: Impact of GERD on Daily Life (NIS)

View source ↗

Summary

AstraZeneca-sponsored clinical trial focusing on the impact of gastroesophageal reflux disease on daily life has completed, providing an update on patient exper…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Snippet

Sponsor: AstraZeneca | Conditions: GERD | Status: COMPLETED